Showing 1 - 9 results of 9 for search 'Miriam Ragle Aure', query time: 0.05s
Refine Results
-
1
-
2
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro by Lisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, Mads Haugland Haugen, Vesa Hongisto, Vessela N. Kristensen, Gunhild Mari Mælandsmo, Kristine Kleivi Sahlberg
Published 2021-05-01
Article -
3
miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer. by Shay Ben-Elazar, Miriam Ragle Aure, Kristin Jonsdottir, Suvi-Katri Leivonen, Vessela N Kristensen, Emiel A M Janssen, Kristine Kleivi Sahlberg, Ole Christian Lingjærde, Zohar Yakhini
Published 2021-02-01
Article -
4
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. by Lisa Svartdal Normann, Mads Haugland Haugen, Vesa Hongisto, Miriam Ragle Aure, Suvi-Katri Leivonen, Vessela N Kristensen, Andliena Tahiri, Olav Engebraaten, Kristine Kleivi Sahlberg, Gunhild Mari Mælandsmo
Published 2023-01-01
Article -
5
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer by Miriam Ragle Aure, Thomas Fleischer, Sunniva Bjørklund, Jørgen Ankill, Jaime A. Castro-Mondragon, OSBREAC, Anne-Lise Børresen-Dale, Jörg Tost, Kristine K. Sahlberg, Anthony Mathelier, Xavier Tekpli, Vessela N. Kristensen
Published 2021-04-01
Article -
6
Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data. by Miriam Ragle Aure, Israel Steinfeld, Lars Oliver Baumbusch, Knut Liestøl, Doron Lipson, Sandra Nyberg, Bjørn Naume, Kristine Kleivi Sahlberg, Vessela N Kristensen, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Zohar Yakhini
Published 2013-01-01
Article -
7
Subtype and cell type specific expression of lncRNAs provide insight into breast cancer by Sunniva Stordal Bjørklund, Miriam Ragle Aure, Jari Häkkinen, Johan Vallon-Christersson, Surendra Kumar, Katrine Bull Evensen, Thomas Fleischer, Jörg Tost, OSBREAC, Kristine K. Sahlberg, Anthony Mathelier, Gyan Bhanot, Shridar Ganesan, Xavier Tekpli, Vessela N. Kristensen
Published 2022-08-01
Article -
8
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer by Deepak Parashar, Anjali Geethadevi, Miriam Ragle Aure, Jyotsna Mishra, Jasmine George, Changliang Chen, Manoj K. Mishra, Andliena Tahiri, Wei Zhao, Bindu Nair, Yiling Lu, Lingegowda S. Mangala, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Amadou K.S. Camara, Mingyu Liang, Janet S. Rader, Ramani Ramchandran, Ming You, Anil K. Sood, Vessela N. Kristensen, Gordon B. Mills, Sunila Pradeep, Pradeep Chaluvally-Raghavan
Published 2019-12-01
Article -
9
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome by Miriam Ragle Aure, Valeria Vitelli, Sandra Jernström, Surendra Kumar, Marit Krohn, Eldri U. Due, Tonje Husby Haukaas, Suvi-Katri Leivonen, Hans Kristian Moen Vollan, Torben Lüders, Einar Rødland, Charles J. Vaske, Wei Zhao, Elen K. Møller, Silje Nord, Guro F. Giskeødegård, Tone Frost Bathen, Carlos Caldas, Trine Tramm, Jan Alsner, Jens Overgaard, Jürgen Geisler, Ida R. K. Bukholm, Bjørn Naume, Ellen Schlichting, Torill Sauer, Gordon B. Mills, Rolf Kåresen, Gunhild M. Mælandsmo, Ole Christian Lingjærde, Arnoldo Frigessi, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Kristine K. Sahlberg, OSBREAC
Published 2017-03-01
Article